nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced technologies for information extraction
|
Thorne, Matthew |
|
1997 |
2 |
2 |
p. 43-45 3 p. |
artikel |
2 |
Arylsulphonylimidazolidinones as anticancer agents
|
|
|
1997 |
2 |
2 |
p. 80- 1 p. |
artikel |
3 |
Automated discovery — faster and cheaper, but better?
|
Hughes, David |
|
1997 |
2 |
2 |
p. 40-43 4 p. |
artikel |
4 |
Bicyclic HIV protease inhibitors
|
|
|
1997 |
2 |
2 |
p. 79- 1 p. |
artikel |
5 |
CCKB antagonists
|
|
|
1997 |
2 |
2 |
p. 79-80 2 p. |
artikel |
6 |
Combinatorial chemistry
|
Wallace, Robert W. |
|
1997 |
2 |
2 |
p. 81-82 2 p. |
artikel |
7 |
CRF1 receptor antagonists
|
|
|
1997 |
2 |
2 |
p. 80- 1 p. |
artikel |
8 |
Cytotoxic natural products
|
|
|
1997 |
2 |
2 |
p. 79- 1 p. |
artikel |
9 |
Gerontology and drug development: The challenge of the senescent cell
|
Faragher, Richard G.A. |
|
1997 |
2 |
2 |
p. 64-71 8 p. |
artikel |
10 |
Growing threat of Gram-positive resistance — a challenge to the industry
|
Hunter, Pamela A. |
|
1997 |
2 |
2 |
p. 47-49 3 p. |
artikel |
11 |
Nonpeptide NMB antagonist
|
|
|
1997 |
2 |
2 |
p. 80- 1 p. |
artikel |
12 |
[No title]
|
Reiss, Revd Dr Michael J. |
|
1997 |
2 |
2 |
p. 49- 1 p. |
artikel |
13 |
Receptor tyrosine kinases as targets for inhibition of angiogenesis
|
Shawver, Laura K. |
|
1997 |
2 |
2 |
p. 50-63 14 p. |
artikel |
14 |
Squalene synthetase inhibitors
|
|
|
1997 |
2 |
2 |
p. 80- 1 p. |
artikel |
15 |
Strategic choices facing the pharmaceutical industry: A case for innovation
|
Drews, Jürgen |
|
1997 |
2 |
2 |
p. 72-78 7 p. |
artikel |
16 |
Virtual molecules!
|
Leach, Martin |
|
1997 |
2 |
2 |
p. 39-40 2 p. |
artikel |